Barbara S. Schnierle

Author

Also Known As

B S Schnierle, B Schnierle, B.S. Schnierle, B. S. Schnierle, Barbara S Schnierle, Barbara S. Schnierle, Barbara Schnierle, Barbara S. Schnierle, S Baylis

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Paul Ehrlich Institut Georg Speyer Haus German Center for Infection Research Philipps University of Marburg Institute of Clinical Cancer Research

About

Barbara S. Schnierle is an author at Paul Ehrlich Institut specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	28	1.1K
2	Cell Biology	11	14	312
3	Natural Sciences	4	4	76
4	Engineering	1	1	66
5	Cellular Therapies	1	1	12

Barbara S. Schnierle

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction Christoph Uherek, Torsten Tonn, Barbara Uherek, Blood	2002	256
Nucleic Acid-Sensing Toll-like Receptors Are Essential for the Control of Endogenous Retrovirus Viremia and ERV-Induced Tumors Philipp Yu, Wolger Lübben, Heike Slomka, Immunity Molecular VirologyErv-induced TumorsHuman RetrovirusImmunologyAntiviral Response	2012	185
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection Arne Auste, Christoph Schürmann, Christin Schmidt, Journal of General Virology	2021	131
The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection Christopher Weber, Katja Sliva, Christine von Rhein, Antiviral Research Insect VirusPlant-virus InteractionGreen Tea CatechinPathogenesisVirology	2014	130
Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells Barbara S. Schnierle, Jörn Stitz, Valerie Bosch, Proceedings of the National Academy of Sciences	1997	126
Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus Entry Markus Hildinger, Matthias T. Dittmar, Patricia Schult-Dietrich, Journal of Virology	2001	109
Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma Christine von Rhein, Tatjana Scholz, Romy Kronstein‐Wiedemann, Journal of Virological Methods Antibody CapacityPotency AssaysViral DiagnosticsCovid-19 PandemicImmunology	2020	101
Recombinant Modified Vaccinia Virus Ankara–Based Vaccine Induces Protective Immunity in Mice against Infection with Influenza Virus H5N1 Joost H. C. M. Kreijtz, Yasemin Suezer, Geert van Amerongen, The Journal of Infectious Diseases	2007	87
Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro Christine von Rhein, Tatjana Weidner, Lisa Henß, Antiviral Research PathogenesisAntiviral TherapyVirologyPlant PathologyMicrobiology	2015	82
Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Tatjana Scholz, Christine von Rhein, Imke Wieters, The Journal of Infectious Diseases	2020	81

Page 1